Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says that the availability of pharmacies nationwide presents a unique situation.
Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says that the availability of pharmacies nationwide presents a unique situation. Pharmacists often serve as providers and clinicians of care as they build relationships with their members. In utilizing this opportunity, they can serve as an educator to patients, especially those with chronic conditions.
In terms of ensuring quality, Dr Berger says that every provider and consumer has a role in taking accountability. “Communication and engagement of all of the members of the healthcare continuum really are necessary in order for healthcare to remain viable in this country,” Dr. Berger stated.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More